(Q33504597)

English

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 July 2017

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer (English)

1 reference

Europe PubMed Central

27 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

V Lorusso

1

1 reference

Europe PubMed Central

27 July 2017

C F Pollera

2

1 reference

Europe PubMed Central

27 July 2017

M Antimi

3

1 reference

Europe PubMed Central

27 July 2017

G Luporini

4

1 reference

Europe PubMed Central

27 July 2017

C Gridelli

5

1 reference

Europe PubMed Central

27 July 2017

G L Frassineti

6

1 reference

Europe PubMed Central

27 July 2017

C Oliva

7

1 reference

Europe PubMed Central

27 July 2017

M Pacini

8

1 reference

Europe PubMed Central

27 July 2017

M De Lena

9

1 reference

Europe PubMed Central

27 July 2017

publication date

1 July 1998

1 reference

Europe PubMed Central

27 July 2017

European Journal of Cancer

1 reference

Europe PubMed Central

27 July 2017

34

1 reference

Europe PubMed Central

27 July 2017

8

1 reference

Europe PubMed Central

27 July 2017

1208-1212

1 reference

Europe PubMed Central

27 July 2017

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of gemcitabine in patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2898%2900030-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(98)00030-6

1 reference

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

27 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33504597&oldid=1535771234"